The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Allergic Asthma Therapeutics Market Research Report 2024
Synopsis
The global Allergic Asthma Therapeutics market was valued at US$ 6655.8 million in 2023 and is anticipated to reach US$ 8092.3 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Allergic Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Asthma Therapeutics.
Report Scope
The Allergic Asthma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergic Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergic Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited
Segment by Type
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segment by Application
Clinic
Research Center
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergic Asthma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Allergic Asthma Therapeutics market was valued at US$ 6655.8 million in 2023 and is anticipated to reach US$ 8092.3 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Allergic Asthma Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergic Asthma Therapeutics.
Report Scope
The Allergic Asthma Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergic Asthma Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergic Asthma Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Infinity Pharmaceuticals, Inc.
Kineta, Inc.
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
Oxagen Limited
Panacea Biotec Limited
Segment by Type
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segment by Application
Clinic
Research Center
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergic Asthma Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ASM-8
1.2.3 AXP-1275
1.2.4 Beta-escin
1.2.5 CHF-6001
1.2.6 CSL-311
1.2.7 Dalazatide
1.2.8 Others
1.3 Market by Application
1.3.1 Global Allergic Asthma Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergic Asthma Therapeutics Market Perspective (2019-2030)
2.2 Allergic Asthma Therapeutics Growth Trends by Region
2.2.1 Global Allergic Asthma Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Allergic Asthma Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Allergic Asthma Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Allergic Asthma Therapeutics Market Dynamics
2.3.1 Allergic Asthma Therapeutics Industry Trends
2.3.2 Allergic Asthma Therapeutics Market Drivers
2.3.3 Allergic Asthma Therapeutics Market Challenges
2.3.4 Allergic Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergic Asthma Therapeutics Players by Revenue
3.1.1 Global Top Allergic Asthma Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Allergic Asthma Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allergic Asthma Therapeutics Revenue
3.4 Global Allergic Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Allergic Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergic Asthma Therapeutics Revenue in 2023
3.5 Allergic Asthma Therapeutics Key Players Head office and Area Served
3.6 Key Players Allergic Asthma Therapeutics Product Solution and Service
3.7 Date of Enter into Allergic Asthma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergic Asthma Therapeutics Breakdown Data by Type
4.1 Global Allergic Asthma Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2025-2030)
5 Allergic Asthma Therapeutics Breakdown Data by Application
5.1 Global Allergic Asthma Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Allergic Asthma Therapeutics Market Size (2019-2030)
6.2 North America Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Allergic Asthma Therapeutics Market Size by Country (2019-2024)
6.4 North America Allergic Asthma Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allergic Asthma Therapeutics Market Size (2019-2030)
7.2 Europe Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Allergic Asthma Therapeutics Market Size by Country (2019-2024)
7.4 Europe Allergic Asthma Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergic Asthma Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Allergic Asthma Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allergic Asthma Therapeutics Market Size (2019-2030)
9.2 Latin America Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Allergic Asthma Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Allergic Asthma Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergic Asthma Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Allergic Asthma Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aslan Pharmaceuticals Pte. Ltd.
11.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Detail
11.1.2 Aslan Pharmaceuticals Pte. Ltd. Business Overview
11.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Introduction
11.1.4 Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
11.2 Axikin Pharmaceuticals, Inc.
11.2.1 Axikin Pharmaceuticals, Inc. Company Detail
11.2.2 Axikin Pharmaceuticals, Inc. Business Overview
11.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.2.4 Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.2.5 Axikin Pharmaceuticals, Inc. Recent Development
11.3 Baxalta Incorporated
11.3.1 Baxalta Incorporated Company Detail
11.3.2 Baxalta Incorporated Business Overview
11.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Introduction
11.3.4 Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.3.5 Baxalta Incorporated Recent Development
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Detail
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Introduction
11.4.4 Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.4.5 Chiesi Farmaceutici SpA Recent Development
11.5 Circassia Pharmaceuticals Plc
11.5.1 Circassia Pharmaceuticals Plc Company Detail
11.5.2 Circassia Pharmaceuticals Plc Business Overview
11.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Introduction
11.5.4 Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.5.5 Circassia Pharmaceuticals Plc Recent Development
11.6 CSL Limited
11.6.1 CSL Limited Company Detail
11.6.2 CSL Limited Business Overview
11.6.3 CSL Limited Allergic Asthma Therapeutics Introduction
11.6.4 CSL Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.6.5 CSL Limited Recent Development
11.7 Fountain Biopharma Inc.
11.7.1 Fountain Biopharma Inc. Company Detail
11.7.2 Fountain Biopharma Inc. Business Overview
11.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Introduction
11.7.4 Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.7.5 Fountain Biopharma Inc. Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Detail
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Hydra Biosciences, Inc.
11.9.1 Hydra Biosciences, Inc. Company Detail
11.9.2 Hydra Biosciences, Inc. Business Overview
11.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Introduction
11.9.4 Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.9.5 Hydra Biosciences, Inc. Recent Development
11.10 Infinity Pharmaceuticals, Inc.
11.10.1 Infinity Pharmaceuticals, Inc. Company Detail
11.10.2 Infinity Pharmaceuticals, Inc. Business Overview
11.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.10.4 Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.10.5 Infinity Pharmaceuticals, Inc. Recent Development
11.11 Kineta, Inc.
11.11.1 Kineta, Inc. Company Detail
11.11.2 Kineta, Inc. Business Overview
11.11.3 Kineta, Inc. Allergic Asthma Therapeutics Introduction
11.11.4 Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.11.5 Kineta, Inc. Recent Development
11.12 Mabtech Limited
11.12.1 Mabtech Limited Company Detail
11.12.2 Mabtech Limited Business Overview
11.12.3 Mabtech Limited Allergic Asthma Therapeutics Introduction
11.12.4 Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.12.5 Mabtech Limited Recent Development
11.13 Marinomed Biotechnologie GmbH
11.13.1 Marinomed Biotechnologie GmbH Company Detail
11.13.2 Marinomed Biotechnologie GmbH Business Overview
11.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Introduction
11.13.4 Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.13.5 Marinomed Biotechnologie GmbH Recent Development
11.14 Mycenax Biotech Inc.
11.14.1 Mycenax Biotech Inc. Company Detail
11.14.2 Mycenax Biotech Inc. Business Overview
11.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Introduction
11.14.4 Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.14.5 Mycenax Biotech Inc. Recent Development
11.15 NeoPharm Co., Ltd.
11.15.1 NeoPharm Co., Ltd. Company Detail
11.15.2 NeoPharm Co., Ltd. Business Overview
11.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Introduction
11.15.4 NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.15.5 NeoPharm Co., Ltd. Recent Development
11.16 Oxagen Limited
11.16.1 Oxagen Limited Company Detail
11.16.2 Oxagen Limited Business Overview
11.16.3 Oxagen Limited Allergic Asthma Therapeutics Introduction
11.16.4 Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.16.5 Oxagen Limited Recent Development
11.17 Panacea Biotec Limited
11.17.1 Panacea Biotec Limited Company Detail
11.17.2 Panacea Biotec Limited Business Overview
11.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Introduction
11.17.4 Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2019-2024)
11.17.5 Panacea Biotec Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
